A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
A Pilot Study of Recombinant Humanized Anti-Interleukin (IL-2) Receptor Antibody (Daclizumab) in Patients With Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia A Pilot Study of Recombinant Humanized Anti-Interleukin (IL-2) Receptor Antibody (Daclizumab) in Pat ...
Aplastic Anemia;Pure Red Cell Aplasia;Diamond Blackfan Anemia